NCT06640725
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06640725
Title Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N (TATIANA)
Acronym TATIANA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Groupe Oncologie Radiotherapie Tete et Cou
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.